Article Listing - Boehringer license novel HIV non-catalytic integrase inhibitors to Gilead

CANADA APPROVES INTERFERON ALFA

27 April 1992

The sale of two new products to treat patients infected with the hepatitis B virus has been approved in Canada....

ISRAELI INDUSTRY FACES PRICE PRESSURE

27 April 1992

In Israel, there have been demands that Hevrat Haovdim and the General Sick Fund, both...

CPMP MEETING DECISIONS

27 April 1992

At a recent meeting of the European Community's Committee for Pro-prietary Medicinal Products, four multi-state and nine concertation (eight variations)...

POST-ELECTION OUTLOOK FOR UK HEALTH SECTOR

20 April 1992

The UK Health and Household sector looks set to continue its period of consolidation and to underperform the stock market...

NITRATES: OLD DRUGS, BUT ONES WITH A FUTURE

20 April 1992

Interest in nitrate products as potential drugs to improve the prognosis of patients with acute myocardial infarction (MI) is steadily...

GEHE SALES AND PROFITS grow IN 1991

20 April 1992

German Drug manufacturer Gehe made group sales in 1991 of just over 5 billion Deutschemarks ($3 billion), an increase of...

US Rx DRUG PRICES UP 4.1% IN 1ST QUARTER

20 April 1992

The US Bureau of Labor Statistics reports that prices of prescription drug products increased by an average of 4.1% in...

STOCK MARKET COMMENTARY: TOKYO

20 April 1992

TOKYO: finished the week with a 6.5% loss at 17,236 yen on Monday April 13, despite a sharp 1,252 point...

APPOINTMENTS AT MARION MERRELL DOW

20 April 1992

Appointments at Marion Merrell Dow: Allan Mills is named as product director for cardiovascular products; Norman Craig is appointed as...

EFAs COULD REFORM ANTIVIRAL THERAPY

20 April 1992

A new approach to treating viral infections, and one which could be synergistic with other antiviral strategies, was described in...

Showing 94421-94430 of 95586 articles